[EN] COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS<br/>[FR] COMPOSITIONS ET METHODES DE TRAITEMENT OU DE PREVENTION DE L'OSTEOPOROSE
申请人:UNIV WESTERN AUSTRALIA
公开号:WO2001001996A1
公开(公告)日:2001-01-11
The invention relates to a composition for treating osteoporosis. More specifically, it relates to a therapeutic composition and method for treating osteoporosis and other calcium, and/or estrogen related disorders.
[EN] THERAPEUTIC RELEASE AGENTS<br/>[FR] AGENTS DE LIBÉRATION THÉRAPEUTIQUES
申请人:ORGANON NV
公开号:WO2008100977A2
公开(公告)日:2008-08-21
[EN] Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof. [FR] L'inhibition pharmacologique de l'activité de l'amide hydrolase d'acides gras (FAAH) entraîne une augmentation des taux d'amides d'acides gras. L'invention concerne des esters d'acides alkylcarbamiques qui constituent des inhibiteurs de l'activité de la FAAH. Les composés décrits inhibent l'activité de la FAAH. L'invention concerne aussi des procédés de préparation d'esters de composés d'acides alkylcarbamiques, des compositions renfermant ceux-ci et des procédés d'utilisation de celles-ci.
The constituents of Eucommia ulmoides OLIV. II. Isolation and structures of three new lignan glycosides.
作者:TAKESHI DEYAMA、TAKAKO IKAWA、SANSEI NISHIBE
DOI:10.1248/cpb.33.3651
日期:——
Three new lignan glycosides were isolated from the bark of Eucommia ulmoides OLIV. (Eucommiaceae). Their structures were established as (-)-olivil 4', 4"-di-O-β-D-glucopyranoside (1), (+)-1-hydroxypinoresinol 4', 4"-di-O-β-D-glucopyranoside (2) and (+)-medioresinol 4'-O-β-D-glucopyranoside (named eucommin A) (3), based on chemical evidence and spectroscopic studies. A known lignan glycoside, (+)-syringaresinol O-β-D-glucopyranoside (4) was also isolated.